Literature DB >> 21726107

Causes of hepatic granuloma: a 12-year single center experience from southern Iran.

Bita Geramizadeh1, Reza Jahangiri, Elham Moradi.   

Abstract

BACKGROUND: Hepatic granuloma is reported in 2 - 15% of liver biopsy specimens. It is relatively easy for the pathologist to diagnose, but sometimes arriving at a specific etiology is quite difficult. Until now, there are few published studies about the etiology of hepatic granuloma in Iran. In this study, we attempt to determine the causes of hepatic granuloma from one of the largest referral centers in this country.
METHODS: In a retrospective study over 12 years, a hepatopathologist reviewed all liver biopsies with granuloma. The medical records, including clinical findings, autoantibodies, viral markers, imaging studies, drug histories, and all other specialized tests, such as molecular studies, were reviewed to reach a definite diagnosis.
RESULTS: During 12 years, there were 72 cases diagnosed with liver granuloma. The most common cause of hepatic granuloma was infectious, with Mycobacterium tuberculosis (52.8%). The second most common cause was visceral leishmaniasis in 8.3% of biopsies. Other less common causes were fungal infections, visceral larva migrans, primary biliary cirrhosis, and hepatitis C, each in 4.2% of cases. Autoimmune hepatitis was diagnosed in 2.8% of patients. Lymphoma, drug induced, disseminated BCGitis, CMV infection, foreign body reaction and sarcoidosis, were each found in 1.4% of the liver biopsies. After all investigations, there were 12.5% idiopathic hepatic granulomas.
CONCLUSION: According to this study, the most common cause of hepatic granuloma in Iran is tuberculosis. This finding is completely different from western countries and very similar to the results of countries such as Saudi Arabia.

Entities:  

Mesh:

Year:  2011        PMID: 21726107     DOI: 0011144/AIM.0012

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  8 in total

Review 1.  Approach to a patient with elevated serum alkaline phosphatase.

Authors:  Asma Siddique; Kris V Kowdley
Journal:  Clin Liver Dis       Date:  2012-04-06       Impact factor: 6.126

2.  Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis.

Authors:  Sonali Paul; Golrokh Javid Sepehr; Barbara Weinstein; Jatin Roper
Journal:  Dig Dis Sci       Date:  2014-08-10       Impact factor: 3.199

Review 3.  A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection.

Authors:  Andrew J Hickey; Lilishia Gounder; Mahomed-Yunus S Moosa; Paul K Drain
Journal:  BMC Infect Dis       Date:  2015-05-06       Impact factor: 3.090

4.  The presence of donor liver granuloma requiring further workup to rule out parasitic disease.

Authors:  Atta Nawabi; Jesus Garcia; Anna Jimenez; Scott Turner; Mojtaba Olyaee; Wei Cui; Timothy Schmitt; Sean Kumer; Mark Reintjes; Ryan Taylor; Judi Olson; Nadia Nawabi; Perwaiz Nawabi
Journal:  J Surg Case Rep       Date:  2017-04-21

Review 5.  Epidemiology and Surgical Management of Foreign Bodies in the Liver in the Pediatric Population: A Systematic Review of the Literature.

Authors:  Francesca Gigola; Chiara Grimaldi; Kejd Bici; Marco Ghionzoli; Claudio Spinelli; Paolo Muiesan; Antonino Morabito
Journal:  Children (Basel)       Date:  2022-01-18

6.  Isolated Hepatic Basidiobolomycosis in a 2-Year-Old Girl: The First Case Report.

Authors:  Bita Geramizadeh; Anahita Sanai Dashti; Mohammad Rahim Kadivar; Shirin Kord
Journal:  Hepat Mon       Date:  2015-08-29       Impact factor: 0.660

Review 7.  Detection of microorganisms in granulomas that have been formalin-fixed: review of the literature regarding use of molecular methods.

Authors:  Jeannette Guarner
Journal:  Scientifica (Cairo)       Date:  2012-12-31

Review 8.  Lessons from other diseases: granulomatous inflammation in leishmaniasis.

Authors:  Paul M Kaye; Lynette Beattie
Journal:  Semin Immunopathol       Date:  2015-12-17       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.